- Solutions Overview
- Clinical Development
- Outsourcing Services
- Parexel® Biotech
- Medical Affairs
- Real-World Evidence and Late Phase
- Our Company
- Management Team
- Diversity, Equity and Inclusion
- Career Opportunities
- Trust & Privacy
May 17 - May 18, 2021
The coronavirus pandemic has changed the world forever. A year ago, virtual clinical trials were a high-interest curiosity; now, they are essential to your pipeline. With the entire drug industry forced into a crash-course on virtual trials, and the uptake curve dangerously light, the early adopters are set for a massive advantage. The time to begin to catch up is now… if you can.
Switching to virtual trials requires more than just running standard methods in front of a webcam. Your entire clinical approach must be reconceptualized in order to get the most benefit from a virtual approach. That’s why you cannot afford to miss the 3rd Virtual Clinical Trials conference – the industry’s leading, longest-lasting conference on this subject, offering you exclusive insights our speaking faculty haven’t shared anywhere else!
|May 18 - 11:30 am - 12:15 pm
2020 and beyond: Sharing pandemic learnings and a future vision for DCTs
Rosamund Round, Vice President, Patient Innovation Center and Decentralized Clinical Trials
Click below to register and use the code: SPONSOR182 to receive a 15% discount on the standard registration rate.
We are always available for a conversation.